Skip to main content
Sitemap
About
About INHN
Towards education
Central Office (Cordoba Unit)
INHN Publisher
Programs
Courses
Interviews
Copyright Policy
How to cite INHN
Website Table of Contents
Last Uploads
Privacy Policy
Search
INHN Legacy website
INHN Projects
Dictionary
Drugs
Photos
Profiles
Controversies
Discoveries
Books
Biographies
Perspectives
Archives
Ebooks
Collated
Multilingual Project
INHN Publisher
INHN 2013. Edited by Peter R. Martin
Treating the Brain: An Odyssey. By Barry Blackwell. Foreword by Edward Shorter
Enhancer Sensitive Brain Regulations and Synthetic Enhancers (Selegiline, BPAP) Which Counteract the Regressive Effects of Brain Aging By Joseph Knoll
Thomas A. Ban: Lithium in Psychiatry in Historical Perspective
François Ferrero: Psychiatry and Antipsychiatry: Inquiry into the Geneva 1980s’ Psychiatry Crisis.
Johan Schioldann: History of the Introduction of Lithium into Medicine and Psychiatry
Peter R. Martin: Historical Vocabulary of Addiction
Contact
You are here:
INHN
INHN Projects
Controversies
Martin M. Katz: Onset of clinical action of antidepressants
Comments by Donald Klein
Response to Martin M. Katz’s’s reply to Carlos Morra’s comment by Donald F. Klein
Dictionary
Drugs
Photos
Profiles
Controversies
Jay D. Amsterdam and Leemon B. McHenry: The Paroxetine 352 Bipolar Study Revisited: Deconstruction of Corporate and Academic Misconduct.
Thomas A. Ban: Conflict of interest in neuropsychopharmacology
Thomas A. Ban: Development of our Vocabulary
Thomas A. Ban: Education in Biological Psychiatry – Homage to Dr. Heinz E. Lehmann
Barry Blackwell: Adumbration; A history lesson
Barry Blackwell: A Tale of Two Pioneers.
Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry
Barry Blackwell: Corporate Corruption in the Psychopharmaceutical Industry. Revised
Barry Blackwell: The anxiety enigma
Barry Blackwell: The Baby and The Bath Water
Barry Blackwell: The lithium controversy: A historical autopsy
Barry Blackwell review, Bessel Van Der Kolk, The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. New York, New York: Viking, 2014; 464 pages.
Pierre Baumann and Francois Ferrero: An official inqury of the clinical research activities (1946-1972) of Roland Kuhn (1912-2005)
John Court: A note on the history of Anorexia Nervosa
James Coyne: Is Moncrieff’s Chemical Imbalance Paper a Decent Systematic Umbrella Review?
Loss, Grief, and Betrayal: Psychiatric Survivors Reflect on the Impact of New Serotonin Study, James Coyne
Paul Devenyi: Addictions are not treatable diseases
Paul Devenyi: Pharmacotherapy of addictions
Camille Drach Hojaij: Stein and Empathic Fulfilment.
François Ferrero: Inquiry of the Geneva 1980s’ Psychiatry Crisis
Max Fink: Reconceptualization of Catatonia.
Ernst J. Franzek: From the dichotomy to a three-part grouping of endogenous psychoses
Samuel Gershon: Brintellix - votioxetine
Samuel Gershon: Device for naltrexone delivery
Samuel Gershon: Ketamine, the “new” breakthrough in the treatment of depression
Samuel Gershon: The emergence of “new” drugs in recent years.
Samuel Gershon: The Tacrine paradigm.
Samuel Gershon: The trazodone cntrovery and its potential fatal consequences
Ken Gillman: Medical science publishing: A slow-motion train wreck
David Healy: Do Randomized Controlled Trials Add to or Subtract from Clinical Knowledge?
David Healy: The shipwreck of the singular
Hanfried Helmchen: The role of psychopharmacotherapy in the early development of social psychiatry in Germany
Carlos R. Hojaij: A Psychopathological Marker For Biological Psychiatry: The Point of No Return and the “Something New" *
Carlos R. Hojaij: “DSM-5: The Future of Psychiatric Diagnosis” or Continuing the Psychiatry DiSMantlement
Carlos R. Hojaij: Psychiatry and Medicine
Carlos R. Hojaij: Towards a Psychiatric Biology
David Janowsky: Cholinergic muscarinic mechanisms in depression and mania
Daniel Kanofsky and Mary E. Woesner: A Fresh Air Approach to COVID-19.
Coyne project, by Mark Kramer.
Martin M. Katz: Component-Specific vs. Diagnosis-Specific Clinical Trial in Depression
Martin M. Katz: Multivantaged vs. conventional assessment method
Martin M. Katz: Onset of clinical action of antidepressants
Comments by Donald Klein
Reply by Martin Katz to Donald Klein’s comment
Response to Martin Katz’s reply by Donald Klein
Response to Donald Klein’s reponse by Martin Katz
Comment on Donald Klein’s comment by Carlos Morra
Response to Martin M. Katz’s response by Donald F. Klein
Response to Donald F. Klein’s response by Martin M. Katz
Reply to Carlos Morra’s comment by Donald F.Klein
Carlos Morra’s response to Donald F. Klein’s reply to his comment
Martin M. Katz’s response to Carlos Morra’s response to Donald F. Klein’s reply to Morra’s comment
Donald F. Klein’s response to Carlos Morra’s response to Klein’s reply to Morra’s comment
Martin M. Katz’s comment on Donald F. Klein’s response to Carlos Morra’s response to Klein’s reply to Morra’s comment
Carlos Morra’s response to Donald F. Klein’s response to Carlos Morra’s response to Klein’s reply to Morra’s comment
Donald F. Klein’s response (2) to Carlos Morra’s (2) response (to Klein’s response to Carlos Morra’s response) to Klein’s reply to Morra’s comment
Response to Donald Klein’s reply to Carlos Morra’s comment by Martin M. Katz
Reply by Martin Katz to Carlos Morra's comment
Response to Martin M. Katz’s’s reply to Carlos Morra’s comment by Donald F. Klein
(current)
Response to Donald F. Klein’s response to his reply to Carlos Morra’s comment by Martin M. Katz
Donald Klein’s correction of his response to Martin M. Katz’s reply to Carlos Morra’s comment
Carlos Morra’s response to Martin M. Katz’s reply to Carlos Morra’s comment
Donald F. Klein’s reply to Martin M. Katz’s comment on Klein’s response to Carlos Morra’s response to Klein’s reply to Morra’s comment
Comment by Elemer Szabadi
Lesley Morey’s comment
Martin M. Katz: The need and rationale for shortenng the clinical trial for antidepressants
Donald F. Klein, Max Fink, Edward Shorter and Thomas A. Ban: Comment exchange on Flagrant Catatonic Behavior.
Joseph Knoll: Controversies on selegiline/(-)-deprenyl’s pharmacological spectrum after more than 50 years of its development
Magda Malewska-Kasprzak, Agnieszka Permoda-Osip, Janusz Rybakowski:Disturbances of the purinergic system in affective disorders and schizophrenia
Trudo Lemmens. “Medical Assistance in Dying” (Euthanasia and Assisted Suicide) in Canada: A Case Raises Questions About Its Use in Patients with Disability and Mental Illness.
Amy S. F. Lutz: The Rise and Fall of the Dexamethasone Suppression Test: Stability, Consensus, Closure.
Gin S. Malhi: A critical analysis of concepts in psychiatry
Antonio E. Nardi, Richard Balon, Guy Chouinard, Fiammetta Cosci, Steven Dubovsky, Giovanni A. Fava, Rafael C. Freire, David J. Greenblatt, John H. Krystal, Karl Rickels, Thomas Roth, Carl Salzman, Richard I. Shader, Edward K. Silberman, Nicoletta Sonino,
János Radó: Renal Toxicity of Lithium in Historical Perspective with Special Reference To Nephrogenic Diabetes Insipidus and its Treatment
Janos Radó: Desmopressin may counteract polyuria in lithium-induced nephrogenic diabetes insipidus. Review of the literature
Shridhar Sharma: Insulin coma treatment: Facts and controversies
Edward Shorter: The Q-T interval and the Mellaril story - a cautionary tale
Leonardo Tondo: Brief History of Suicide in Western Cultures
Hector Warnes: The gut-brain axis
Hector Warnes: Pyridoxine in the treatment of lithium-induced tremor.
Discoveries
Books
Biographies
Perspectives
Archives
Ebooks
Collated
Multilingual Project
Donald F. Klein’s response to Martin M. Katz’s reply to Carlos Morra’s comment
CLICK ON IMAGE TO OPEN PDF
